Latest Pneumococcal polysaccharide vaccine Stories

Commonly used pneumococcal polysaccharide vaccines do not appear to be effective in preventing pneumonia, Swiss and British researchers said. Dr. Matthias Egger of the University of Bern, Switzerland, and colleagues said that in many industrialized countries, pneumococcal vaccines are currently recommended to help prevent pneumonia in those age 65 and older, and for younger people with increased risk due to conditions like HIV. The study, a systematic review and meta-analysis, looked at 22...

WASHINGTON, Oct. 27 /PRNewswire-FirstCall/ -- Data from a pivotal trial and three other Phase 3 studies presented today indicate that Wyeth's investigational 13-valent pneumococcal conjugate vaccine (PCV13) may offer broader protection against pneumococcal disease (PD) in infants and young children compared to Prevnar(R), Pneumococcal 7-valent Conjugate Vaccine (Diphtheria CRM197 Protein). Specifically, the data indicate that PCV13 may be as effective as Prevnar (also referred to as PCV7)...

The U.S. Centers for Disease Control and Prevention's (CDC) Advisory Committee on Immunization Practices (ACIP) voted unanimously yesterday to recommend that adults ages 19 to 64 with asthma receive pneumococcal polysaccharide vaccine (PPSV23), known as PNEUMOVAX(R) 23 (Pneumococcal Vaccine Polyvalent). Merck & Co., Inc. is the sole supplier of PNEUMOVAX 23 in the United States. The ACIP based this recommendation on study data that showed an increased risk of pneumococcal disease among people...

A vaccination to protect against the bacteria that can cause pneumonia, meningitis and other diseases is now available for smokers. A government panel recommends that adult smokers under the age of 65 be given the pneumococcal vaccine which is already administered to anyone 65 or older.  These pneumococcal infections affect the elderly in particular and are common complications of the flu and are top killers among the diseases that can be prevented by vaccination.  Smokers are about...

U.S. scientists say the discovery of a new mechanism of immunity suggests a more effective pneumococcal vaccine might be in the offing. Children's Hospital Boston and Harvard School of Public Health researchers say there might be a better way to protect people against Streptococcus pneumoniae infection. They said the current vaccine, Prevnar, is expensive and covers only 7 of the 91 known pneumococcal strains. Dr. Richard Malley and medical researcher Marc Lipsitch discovered that, in...

COLLEGEVILLE, Pa., Sept. 23 /PRNewswire/ -- Wyeth Pharmaceuticals, a division of Wyeth , today announced the initiation of the Community Acquired Pneumonia Immunization Trial in Adults a major study in adults of an investigational 13-valent conjugate vaccine designed to help prevent pneumococcal pneumonia -- the leading cause of bacterial pneumonia in adults. In Europe and the United States, pneumococcal pneumonia is the most common community-acquired bacterial pneumonia, for which the...

COLLEGEVILLE, Pa., Sept. 15 /PRNewswire-FirstCall/ -- Wyeth Pharmaceuticals, a division of Wyeth , today announced that South Africa has initiated an immunization program against pneumococcal disease with PREVENAR(R) (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed), a vaccine which helps protect infants and young children against the seven vaccine serotypes causing the majority of pneumococcal disease worldwide. The South African government launched the pneumococcal disease...

MAIDENHEAD, England, September 4 /PRNewswire-FirstCall/ -- - Prevenar Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Worldwide Wyeth today announced that Cyprus and the Republic of Ireland have initiated national immunisation programmes (NIPs) for infants and young children against pneumococcal disease by adding Prevenar(TM) (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed), also called PCV7, to their national immunization...

Reportlinker.com announces that a new market research report related to the Pharmaceutical industry industry is available in its catalogue. Commercial and Pipeline Insight: Vaccines for Adults and the Elderly - New blockbuster opportunities ahead http://www.reportlinker.com/p091765/Commercial-and-Pipeline-Insight-Vaccines-for-Adults-and-the-Elderly---New-blockbuster-opportunities-ahead.html Introduction Vaccines have re-emerged as successful revenue generators for Big Pharma, with adults...

MAIDENHEAD, England, July 8 /PRNewswire-FirstCall/ -- - PREVENAR Vaccine to Help Protect Children Against the Leading Vaccine-Preventable Cause of Death in Young Children Wyeth applauds the countries of Cyprus, Hungary, the Kingdom of Bahrain, Republic of Ireland, Slovak Republic and Sweden for announcing their decisions to routinely immunize infants and young children against pneumococcal disease by adding PREVENAR(TM) PCV7 (Pneumococcal Saccharide Conjugated Vaccine, Adsorbed) to their...